N0001924C0061

NGJ LB CB1 DEVELOPMENT

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Defense
Office	NAVAL AIR SYSTEMS COMMAND
NAICS	541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC	AC14 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; R&D ADMINISTRATIVE EXPENSES
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	COST PLUS INCENTIVE FEE
Obligations	$265.1M
Current contract value	$588.9M
Potential contract value / ceiling	$588.9M
Start date	Aug 26, 2024
Current end date	Aug 24, 2029
Potential end date	Aug 24, 2029
Latest award activity	May 11, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
May 11, 2026	P00017	$30.5M	THIS MODIFICATION INCREMENTALLY FUNDS CLINS 0001 & 0008.
Mar 19, 2026	P00016	$50.0M	THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001.
Feb 24, 2026	P00015	$5.0M	THIS MODIFICATION PROVIDES INCREMENTAL FUNDING UNDER CLIN 0001.
Jan 13, 2026	P00014	$10.0M	THIS MODIFICATION PROVIDES INCREMENTAL FUNDING UNDER CLIN 0001.
Jan 6, 2026	P00013	$0	THIS NO-COST MODIFICATION UPDATES CLAUSE H-1 AND SECTION J EXS (A) & (B), AND ATTS (1), (2), AND (4).
Nov 20, 2025	P00012	$22.0M	LB INCREMENTAL FUNDING
Sep 24, 2025	P00011	$189.1K	THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001.
Aug 14, 2025	P00010	$5.2M	THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001.
Jun 26, 2025	P00009	$0	THIS MODIFICATION UPDATES THE TPOC AND CLAUSE HTXT.245-0001.
May 19, 2025	P00008	$19.6M	THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001.
May 15, 2025	P00007	$0	THIS MODIFICATION UPDATES SECTION J ATT (3) AND CLAUSES IN ACCORDANCE WITH EXECUTIVE ORDERS.
May 1, 2025	P00006	$0	THIS MODIFICATION AMENDS SECTION J EX(A) AND ATTS (1), (3), (8), & (9). THIS MODIFICATION ALSO INCORPORATES CLAUSE HTXT.245-0001 AND REMOVES/AMENDS CLAUSES IN ACCORDANCE WITH E.O. 14173.
Mar 10, 2025	P00005	$25.0M	THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001.
Jan 28, 2025	P00004	$12.0M	THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0001.
Dec 12, 2024	P00003	$9.4M	THIS MODIFICATION INCREMENTALLY FUNDS CLIN 0001.
Dec 6, 2024	P00002	$0	ADMIN UPDATES TO SECTION F AND SECTION J
Sep 18, 2024	P00001	$0	ADD PAYMENT CLAUSE
Aug 26, 2024	0	$76.2M	NGJ LB CB1 DEVELOPMENT

Estimated positioning window

Aug 24, 2028 – Feb 24, 2029

Recompete signal:

45/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 45/100. Available recorded signals: 40 points.

Contract end 2029-08-24 (1027 days from calculation): +15 points
1 historical awards in this buyer and category group: +0 points
18 recorded award transactions: +10 points
Latest award action: 2026-05-11: +5 points
Parent award identifier recorded: +0 points
Solicitation identifier recorded: +10 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Check the stated set-aside against the solicitation and current certifications.
Review the award scope and buyer evidence before making a bid/no-bid decision.